Clinical Trial Update: Effect of Ellagic Ácid on the Components of Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the effect of ellagic acid on metabolic syndrome components, insulin sensitivity, and insulin secretion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• ellagic acid (ellagic acid)

Snippet

Sponsor: University of Guadalajara | Conditions: Metabolic Syndrome | Phase 2 | Status: UNKNOWN